Rondon-Berrios H
Department of Internal Medicine, University of New Mexico School of Medicine, University of New Mexico, Albuquerque, New Mexico,
Nefrologia. 2011;31(2):148-54. doi: 10.3265/Nefrologia.pre2010.Nov.10724.
Oedema is a common clinical manifestation of nephrotic syndrome. However, the pathophysiological mechanism of sodium retention in nephrotic syndrome has been intensely debated for decades. Several clinical and experimental observations argue against the classic or "underfill" hypothesis of oedema formation in nephrotic syndrome. In many patients, oedema formation in nephrotic syndrome is due to the kidney being intrinsically unable to excrete salt and is unrelated to systemic factors (i.e. hypoalbuminaemia, decreased “effective” arterial blood volume, and secondary hyperaldosteronism). The cortical collecting duct is the nephron site of sodium retention in nephrotic syndrome. Activation of the epithelial sodium channel in the cortical collecting duct is responsible for sodium retention in nephrotic syndrome. In nephrotic syndrome, a defective glomerular filtration barrier allows the passage of proteolytic enzymes or their precursors, which have the ability to activate the epithelial sodium channel, thereby causing the the subsequent sodium retention and oedema.
水肿是肾病综合征常见的临床表现。然而,数十年来,肾病综合征中钠潴留的病理生理机制一直存在激烈争论。一些临床和实验观察结果对肾病综合征水肿形成的经典或“血容量不足”假说提出了质疑。在许多患者中,肾病综合征的水肿形成是由于肾脏本身无法排泄盐分,与全身因素(即低白蛋白血症、“有效”动脉血容量减少和继发性醛固酮增多症)无关。皮质集合管是肾病综合征中钠潴留的肾单位部位。皮质集合管上皮钠通道的激活是肾病综合征钠潴留的原因。在肾病综合征中,有缺陷的肾小球滤过屏障允许蛋白水解酶或其前体通过,这些物质有能力激活上皮钠通道,从而导致随后的钠潴留和水肿。